Withuspharmaceutical (Korea) Top Management
330350 Stock | KRW 6,600 360.00 5.77% |
Analysis of Withuspharmaceutical's management performance can provide insight into the company performance.
Withuspharmaceutical |
Symbol | 330350 |
Name | Withuspharmaceutical CoLtd |
Type | Stock |
Country | Republic of Korea |
Exchange | KQ |
Information on Withuspharmaceutical CoLtd Leadership is currently not available.
If you believe this information is not accurate please let us know and we will check it out. Check all delisted instruments across multiple markets.Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Thematic Opportunities
Explore Investment Opportunities
Withuspharmaceutical Management Team Effectiveness
The company has return on total asset (ROA) of 0.0664 % which means that it generated a profit of $0.0664 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 6.6165 %, meaning that it generated $6.6165 on every $100 dollars invested by stockholders. Withuspharmaceutical's management efficiency ratios could be used to measure how well Withuspharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.Withuspharmaceutical Workforce Comparison
Withuspharmaceutical CoLtd is currently under evaluation in number of employees category among its peers. The total workforce of Pharmaceuticals industry is presently estimated at about 677. Withuspharmaceutical adds roughly 0.0 in number of employees claiming only tiny portion of equities listed under Pharmaceuticals industry.
The company has Profit Margin (PM) of 0.12 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.14 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.14. Withuspharmaceutical Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Withuspharmaceutical Price Series Summation is a cross summation of Withuspharmaceutical price series and its benchmark/peer.
About Withuspharmaceutical Management Performance
The success or failure of an entity such as Withuspharmaceutical often depends on how effective the management is. Withuspharmaceutical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Withuspharmaceutical management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Withuspharmaceutical management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Withus Pharmaceutical Co., Ltd. produces and sells pharmaceutical products in South Korea. The company was founded in 2005 and is headquartered in Seoul, South Korea. Withus Pharm is traded on Korean Securities Dealers Automated Quotations in South Korea.
Please note, the presentation of Withuspharmaceutical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Withuspharmaceutical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Withuspharmaceutical's management manipulating its earnings.
Complementary Tools for Withuspharmaceutical Stock analysis
When running Withuspharmaceutical's price analysis, check to measure Withuspharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Withuspharmaceutical is operating at the current time. Most of Withuspharmaceutical's value examination focuses on studying past and present price action to predict the probability of Withuspharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Withuspharmaceutical's price. Additionally, you may evaluate how the addition of Withuspharmaceutical to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |